Live Analyst Rating Changes 1511 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ben Klieve
BENC
Ben Klieve
Wall Street Analyst
★☆☆☆☆
#2498
on 13Foresight · ranked by our own returns
38%
Success Rate
-12.5%
Average Return
14 of 37 calls profitable · -21.4% vs benchmark
📈 Across the calls we could measure, roughly 38% of Ben Klieve's ratings turned a profit when each position was held for 1 year — averaging -12.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

61 Buy 3 Hold 0 Sell
Ben's Stock Coverage 38 ratings · 2026-06-19
Company Date Position Consensus Price Target 1-Yr Return
IFF
International Flavors & Fragrances
Jun 09, 2026 BUY Strong Buy
+29.3% avg upside
27 analysts
$100.00
30.35% Upside
+0.7%
ANDE
The Andersons
May 07, 2026 BUY Strong Buy
+18.5% avg upside
4 analysts
$90.00
26.39% Upside
-3.3%
INGR
Ingredion
Mar 17, 2026 BUY Hold
+24.5% avg upside
8 analysts
$130.00
32.77% Upside
-12.0%
TATT
Tat Techno
Mar 12, 2026 BUY Strong Buy
+24.7% avg upside
7 analysts
$66.00
41.07% Upside
-24.5%
VITL
Vital Farms
Feb 26, 2026 HOLD Buy
+79.2% avg upside
15 analysts
-57.4%
MGPI
MGP Ingredients
Jan 22, 2026 BUY Strong Buy
+249.6% avg upside
7 analysts
$35.00
112.98% Upside
-27.1%
LWAY
Lifeway Foods
Jan 14, 2026 BUY Buy
+37.6% avg upside
2 analysts
$35.00
37.59% Upside
+14.0%
CALM
Cal-Maine Foods
Jan 08, 2026 BUY Hold
-4.8% avg upside
7 analysts
$100.00
28.73% Upside
+3.4%
CHEF
The Chefs' Warehouse
Oct 30, 2025 BUY Strong Buy
-25.8% avg upside
11 analysts
$80.00
16.10% Downside
+34.0%
SRTA
Strata Critical Medical
Sep 17, 2025 BUY Strong Buy
+20.6% avg upside
11 analysts
$7.25
23.39% Upside
·
BIOX
Bioceres Crop Solutions
Sep 10, 2025 BUY Buy
+3319.2% avg upside
5 analysts
$5.00
1240.92% Upside
-78.3%
LMNR
Limoneira Co
Sep 09, 2025 BUY Strong Buy
+73.9% avg upside
6 analysts
$23.00
75.89% Upside
-14.9%
AVO
Mission Produce
Sep 09, 2025 BUY Strong Buy
+48.7% avg upside
8 analysts
$18.00
56.57% Upside
-8.6%
TITN
Titan Machinery
Aug 29, 2025 HOLD Buy
-1.7% avg upside
8 analysts
$18.00
13.02% Downside
-2.9%
EVGN
Evogene
Aug 20, 2025 BUY Strong Buy
+1918.8% avg upside
6 analysts
$3.50
566.59% Upside
-37.7%
AVD
American Vanguard
Aug 19, 2025 BUY Strong Buy
+824.5% avg upside
4 analysts
$12.00
352.80% Upside
-49.3%
RKDA
Arcadia Biosciences
Aug 15, 2025 BUY Strong Buy
+1149.7% avg upside
3 analysts
$12.00
1443.62% Upside
-80.2%
LOCL
Local Bounti Corporation
Aug 13, 2025 BUY Strong Buy
+326.4% avg upside
3 analysts
$6.00
365.19% Upside
-5.5%
SANW
S&W Seed Company
Jun 24, 2025 BUY Strong Buy
+42122.3% avg upside
3 analysts
$25.00
83233.41% Upside
-98.5%
AQB
AquaBounty Technologies
Nov 06, 2024 HOLD Buy
+502.8% avg upside
5 analysts
$1.00
6.40% Upside
-3.6%
YTENQ
Yield10 Bioscience
May 17, 2024 HOLD Buy
+37874900.0% avg upside
6 analysts
$2.50
2499900.07% Upside
·
BHILQ
Benson Hill
Aug 10, 2023 BUY Strong Buy
+96249900.0% avg upside
3 analysts
$87.50
87499899.99% Upside
-81.5%
SHPWQ
Shapeways Holdings
Mar 31, 2023 BUY Strong Buy
+483333233.3% avg upside
4 analysts
$8.00
799999900.04% Upside
·
LEO
BNY Mellon Strategic Municipals, Inc.
Nov 08, 2021 BUY Strong Buy
+134.1% avg upside
1 analyst
$15.00
134.05% Upside
-25.9%
SMR
NuScale Power
Oct 15, 2021 HOLD Buy
+40.2% avg upside
18 analysts
+9.7%
CBUS
Cibus
Nov 06, 2020 HOLD Strong Buy
+1170.7% avg upside
10 analysts
$6.00
341.11% Upside
+3.7%
CACI
Caci International
Oct 18, 2018 HOLD Buy
-6.4% avg upside
28 analysts
+24.4%
AIR
AAR
Oct 08, 2018 HOLD Strong Buy
-8.7% avg upside
10 analysts
-11.2%
CMTL
Comtech Telecommunications
Sep 27, 2018 BUY Buy
+904.1% avg upside
10 analysts
$38.00
1483.24% Upside
+3.6%
DCO
Ducommun
Sep 25, 2018 BUY Strong Buy
-16.2% avg upside
8 analysts
$42.00
74.34% Downside
+6.0%
KTOS
Kratos Defense
Sep 14, 2018 BUY Strong Buy
+68.2% avg upside
25 analysts
$20.00
63.20% Downside
+45.0%
ICFI
Icf International
Aug 29, 2018 HOLD Strong Buy
+43.9% avg upside
11 analysts
+4.9%
DLHC
DLH Holdings
Aug 27, 2018 BUY Strong Buy
+91.5% avg upside
4 analysts
$8.25
51.60% Upside
-24.9%
CVU
CPI Aerostructures
Aug 09, 2018 BUY Buy
+34.2% avg upside
5 analysts
$11.00
121.42% Upside
-3.5%
VVX
V2X
Aug 08, 2018 HOLD Buy
-7.8% avg upside
16 analysts
+22.4%
AIN
Albany International
Aug 08, 2018 HOLD Hold
+3.2% avg upside
9 analysts
+11.0%
III
Information Services Group
Aug 07, 2018 BUY Strong Buy
+102.7% avg upside
8 analysts
$5.25
30.85% Upside
-43.9%
ORN
Orion Group Holdings
May 04, 2018 BUY Strong Buy
-24.2% avg upside
15 analysts
$10.00
37.01% Downside
-59.5%
🔒 33 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Ben Klieve — Frequently Asked Questions
How accurate are Ben Klieve's stock ratings?
Based on the calls 13Foresight could measure, about 38% of Ben's ratings were profitable over a one-year hold, with an average return of -12.5% per rating, or -21.4% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Ben ranked on 13Foresight?
Ben Klieve is currently ranked #2498 with a 1-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ben cover?
Ben most recently has ratings on IFF, ANDE, INGR, TATT, VITL, MGPI, LWAY, CALM, CHEF, SRTA, BIOX, LMNR and 26 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.